Glaukos (GKOS) Gross Profit Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 5.02% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.10% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 4.54% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 15.44% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 9.03% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.15% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 17.49% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 1.49% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 8.46% |
| 10 | Glaukos | 6.00 Bn | 5.90 Bn | 117.23 Mn | 28.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.06% |
| Dec 31, 2025 | -26.58% |
| Sep 30, 2025 | 24.39% |
| Jun 30, 2025 | 21.02% |
| Mar 31, 2025 | 17.61% |
| Dec 31, 2024 | 10.89% |
| Sep 30, 2024 | 7.68% |
| Jun 30, 2024 | 6.63% |
| Mar 31, 2024 | 8.39% |
| Dec 31, 2023 | 5.77% |
| Sep 30, 2023 | 8.28% |
| Jun 30, 2023 | 82.68% |
| Mar 31, 2023 | 34.77% |
| Dec 31, 2022 | 2.64% |
| Sep 30, 2022 | 2.31% |
| Jun 30, 2022 | 2.64% |
| Mar 31, 2022 | 2.56% |
| Dec 31, 2021 | 6.28% |
| Sep 30, 2021 | 16.12% |
| Jun 30, 2021 | 17.70% |
| Mar 31, 2021 | 14.33% |
| Dec 31, 2020 | 13.16% |
| Sep 30, 2020 | 10.57% |
| Jun 30, 2020 | -34.85% |
| Mar 31, 2020 | -9.46% |
| Dec 31, 2019 | 20.76% |
| Sep 30, 2019 | 25.52% |
| Jun 30, 2019 | 27.99% |
| Mar 31, 2019 | 32.93% |
| Dec 31, 2018 | 41.20% |
| Sep 30, 2018 | 34.19% |
| Jun 30, 2018 | 36.74% |
| Mar 31, 2018 | 42.49% |
| Dec 31, 2017 | 58.92% |
| Sep 30, 2017 | 52.00% |
| Jun 30, 2017 | 59.82% |
| Mar 31, 2017 | 69.54% |